Flixotide Evohaler

Flixotide 125 micrograms Evohaler is a pressurised inhalation suspension, delivering 125 micrograms of fluticasone propionate per actuation. Therapeutic indications: Fluticasone propionate given by inhalation offers prophylactic treatment for asthma. Adults: Mild asthma: Patients requiring intermittent symptomatic bronchodilator asthma medication on a regular daily basis.